4//SEC Filing
Medmira Capital Ltd. 4
Accession 0001209191-21-048086
CIK 0001828673other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 7:32 PM ET
Size
11.2 KB
Accession
0001209191-21-048086
Insider Transaction Report
Form 4
Medmira Capital Ltd.
10% Owner
Transactions
- Conversion
Common Stock
2021-07-22+730,519→ 3,587,661 total - Conversion
Series B Redeemable Preferred Stock
2021-07-22−2,857,142→ 0 total→ Common Stock (2,857,142 underlying) - Conversion
Common Stock
2021-07-22+2,857,142→ 2,857,142 total - Conversion
Series C Redeemable Preferred Stock
2021-07-22−730,519→ 0 total→ Common Stock (730,519 underlying)
Footnotes (2)
- [F1]Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
- [F2]Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
IncorporatedChina
Related Parties
1- filerCIK 0001872543
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 7:32 PM ET
- Size
- 11.2 KB